triparanol has been researched along with spironolactone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, S; Kitani, T; Matsuzawa, Y; Seki, K; Yamamoto, A | 1 |
Siegenthaler, W; Werning, C | 1 |
HOFFMEISTER, W | 1 |
1 review(s) available for triparanol and spironolactone
Article | Year |
---|---|
[Drug-induced lipidosis: formation of myeloid bodies (author's transl)].
Topics: Animals; Diethylamines; Ethanolamines; Gangliosides; Haplorhini; Hexestrol; Humans; Inclusion Bodies; Leukocytes; Lipid Metabolism; Lipidoses; Liver; Male; Microscopy, Electron; Middle Aged; Phospholipids; Rats; Ribosomes; Spironolactone; Spleen; Triparanol | 1974 |
2 other study(ies) available for triparanol and spironolactone
Article | Year |
---|---|
[Therapy of secondary hyperaldosteronism].
Topics: Aminoglutethimide; Butanones; Heparin; Humans; Hyperaldosteronism; Metyrapone; Mineralocorticoid Receptor Antagonists; Spironolactone; Triamterene; Triparanol | 1973 |
[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extracellular Space; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Kidney Tubules; Liver Cirrhosis; Metyrapone; Mineralocorticoid Receptor Antagonists; Natriuresis; Nephrotic Syndrome; Pathology; Pharmacology; Physiology; Potassium; Sodium; Spironolactone; Toxicology; Triparanol | 1964 |